“…Aberrant protein citrullination is a hallmark of multiple autoimmune disorders, including rheumatoid arthritis (RA), multiple sclerosis (MS), ulcerative colitis (UC), and lupus, as well as several neurodegenerative diseases and cancer. Of note, multiple pan-and isozyme-selective PAD inhibitors are known and these inhibitors show efficacy in animal models of RA, UC, MS, lupus, and sepsis 1,8,[10][11][12] . The contribution of protein hypercitrullination to the pathology of various diseases has been further established using the phenylglyoxal (PG)-based citrulline (Cit)specific probes, Rhodamine-PG (Rh-PG) and Biotin-PG 1,8 .…”